Illumina
Overview

Date:
26th February 2025, Wednesday

Time:
12:00 pm - 01:00 pm (Dubai)
01:30 pm - 02:30 pm (Delhi)
04:00 pm - 05:00 pm (Singapore)
05:00 pm - 06:00 pm (Seoul / Tokyo)
07:00 pm - 08:00 pm (Melbourne)

Register Now
We understand that our webinar timing may not suit your busy schedule. Please feel free to register to get the on-demand recording link once it is ready.

Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.

Speaker:

Ritika Chaturvedi
Senior Technical Application Scientist,
Illumina

Ritika holds a Master’s degree in Biotechnology from the Indian Institute of Technology Guwahati (IIT-G) in India. She has an experience of more than 10 years working in the field of genomics with extensive knowledge in NGS applications and data analysis. In her career, she has gained experience in clinical laboratory management and working as a Field Application Scientist, helping customers in trainings and in technical support. Ritika is passionate about using her knowledge and experience in troubleshooting technical challenges. She joined Illumina in 2022 as a Senior Technical Applications Scientist. Since then, she has specialized in supporting customers in instrumentation, software analysis and clinical workflows.
Register below to watch the webinar.
Company Legal
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.